Batteries for clean energy


Opportunities for game-changers

Timeline to commercial success


Ambri develops and qualifies commercial cells


Initial demonstration systems deployed


1 MWh Commercial system developed, certified and deployed for trials


250 MWh production shipped for commercial projects

Ambri facility

Ambri batteries are currently produced in our 40,000+ square foot facility in Marlborough, MA, a 40-minute drive from downtown Boston. The facility is designed for fabrication and testing of our commercial cell products.

Future plans include partnerships for cell manufacturing in each major region of the world.


Poised for accelerated growth

The energy storage market is projected to exceed $50B in annual system revenue in 2030 and Ambri is projecting a sizable share of cell sales at that time.

Ambri has raised over $70 million in equity financing since its founding in 2010. Ambri’s investors include Bill Gates, Khosla Ventures, Total, KLP Enterprises, and Building Insurance Bern (GVB). Our investors share a long-term belief that our electricity storage technology will transform the electric power industry everywhere.

Manufacturing Partners (Licensees)

Ambri’s cells are currently manufactured internally. The cell’s simple design and manufacturing process allow for low-cost, high volume production facilities in different regions of the world.

Ambri is interested in working with manufacturers that have demonstrated success producing high quality and low-cost energy products to help meet the anticipated demand for energy storage installations worldwide.

System Integrators

Ambri’s manufacturing partners will sell containerized DC-systems to system integrators who will manage the integration with inverters switchgear, energy management controls, and other AC-level system elements. System integrators will also install and commission full AC-systems for project developers, utilities, or IPPs.

A unique, patented solution

The Ambri batteries were created from patented technology developed by Ambri and the GroupSadoway lab at MIT. Our IP Portfolio contains more than 50 issued patents in the US and around the world. These broad patents cover cell chemistry, cell components, cell construction, cell- to- cell interconnects, system designs, battery management system designs and manufacturing processes. This strong global patent portfolio ensures our unique positioning in the marketplace.